Cochrane · systematic review · CD011858

Anticoagulation for people receiving long‐term haemodialysis

Natale, P, Palmer, SC, Ruospo, M, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library

Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
4
No studies
3
Included studies
NR
No studies 3 · 42.9%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 57.1%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Low molecular weight heparin versus unfractionated heparin for haemodialysis‐related anticoagulation

Population: adults with kidney failure treated with long‐term HD
7 questions
OutcomeEffectEvidenceStatus / GRADE
Extracorporeal circuit thrombosis Median
Low molecular weight heparin vs unfractionated heparin
1.58 [0.46, 5.42]3 studies · 91 participantsLow
Downgraded: risk of bias
Major bleeding Median
Low molecular weight heparin vs unfractionated heparin
no estimate extractedNRNo studies
Death (any cause) Median
Low molecular weight heparin vs unfractionated heparin
RR 2.64 [0.51, 13.83]3 studies · 120 participantsLow
Downgraded: risk of bias
Dialysis vascular access thrombosis Median
Low molecular weight heparin vs unfractionated heparin
RR 0.2 [0.01, 3.7]2 studies · 45 participantsLow
Downgraded: risk of bias
Dialysis vascular adequacy (Kt/V)
Low molecular weight heparin vs unfractionated heparin
no estimate extracted1 study · 20 participantsLow
Downgraded: risk of bias
Minor bleeding Median
Low molecular weight heparin vs unfractionated heparin
no estimate extractedNRNo studies
Blood transfusion
Low molecular weight heparin vs unfractionated heparin
no estimate extractedNRNo studies